Kenneth Ellenbogen, MD
Clinical Cardiac Electrophysiology · Richmond, VANPI 1508966706
Payments from drug & device makers
What this record shows
This record is dominated by speaking fees: $227,301 of the $360,080 with a category attached, or 63.1%. 15 manufacturers reported payments, led by Medtronic at 44.8% of the total. Reporting peaked in 2019 at $79,081 and has fallen 60.2% since, to $31,457 in 2025. Among clinical cardiac electrophysiology clinicians in VA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 406 payments — averaging $886.90 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Medtronic$161K
- Boston Scientific$111K
- Biotronik Inc.$24K
- Biosense Webster, Inc.$11K
- Medical Device Business Services, Inc.$11K
- Impulse Dynamics (USA) Inc.$9K
- plus $32K from 9 others
Across 184 payments — averaging $5640.13 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Boston Scientific$650K
- Medical Device Business Services, Inc.$266K
- Biosense Webster, Inc.$108K
- Genentech, Inc.$11K
- Ipsen Pharma SAS$3K
- Medtronic$281
What the payments were for
- Consulting fees$96,69027%
- Speaking & faculty fees$227,30163%
- Travel & lodging$24,8817%
- Food & beverage$11,1113%
- Education$970%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Medtronic(2 entities) | 157 | $161,155 |
| Boston Scientific | 121 | $111,066 |
| Biotronik Inc. | 33 | $23,575 |
| Biosense Webster, Inc. | 26 | $11,346 |
| Medical Device Business Services, Inc. | 16 | $11,203 |
| Impulse Dynamics (USA) Inc. | 12 | $9,287 |
| Abbott | 27 | $9,122 |
| Sanofi-aventis U.S. LLC | 2 | $7,187 |
| Kestra Medical Technology Services, Inc. | 3 | $5,500 |
| GE HealthCare | 4 | $5,400 |
| ZOLL Services LLC (a/k/a ZOLL Lifecor Corp) | 1 | $3,500 |
| Atricure, Inc. | 1 | $1,200 |
| Altathera Pharmaceuticals LLC | 1 | $500 |
| Siemens Medical Solutions USA, Inc. | 1 | $24 |
| Johnson & Johnson | 1 | $15 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- GENERAL - THERAPIES$52,379
- WATCHMAN Access System$16,423
- Carto 3 System$12,536
- Watchman$11,341
- Carto 3$10,997
- GENERAL EP$9,005
- OPTIMIZER$8,948
- Edora$8,205
- Rivacor$8,205
- Acticor$8,205
- MULTAQ$7,154
- Sentus$6,682
- Plexa$6,682
- Assure WCD$5,500
- ENSITE PRECISION$5,306
- VersaCross Access Solution$5,100
- Carto Smarttouch$4,550
- Arctic Front$3,579
- LifeVest$3,500
- OPTIMIZER SMART SYSTEM$3,000
How this compares
$360,080 in reported general payments places this provider in the 95th percentile of 90 clinical cardiac electrophysiology providers in Virginia.
See all clinical cardiac electrophysiology providers in Virginia →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 1,052 | $1,131,298 |
| XareltoRivaroxaban | 336 | $358,086 |
| JardianceEmpagliflozin | 85 | $82,158 |
| EntrestoSacubitril/Valsartan | 67 | $66,628 |
| Dofetilide | 334 | $58,949 |
| FarxigaDapagliflozin Propanediol | 45 | $34,773 |
| Dabigatran EtexilateDabigatran Etexilate Mesylate | 16 | $5,074 |
| Metoprolol Succinate | 400 | $4,790 |
| Flecainide Acetate | 113 | $4,457 |
| Amiodarone Hcl | 348 | $4,250 |
| SotalolSotalol Hcl | 147 | $2,981 |
| Propafenone Hcl ErPropafenone Hcl | 18 | $2,914 |
| Potassium Chloride | 90 | $2,534 |
| Diltiazem 24hr Er (Cd)Diltiazem Hcl | 42 | $1,700 |
| Propafenone Hcl | 25 | $1,659 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Johnson & JohnsonXarelto | $15 | $358,086336 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 90 clinical cardiac electrophysiology providers in Virginia.
Other clinical cardiac electrophysiology in Richmond
- Ajay PillaiRichmond$129K
- Charles JoynerRichmond$85K
- Binaya BasyalRichmond$79K
- Jayanthi KoneruRichmond$62K
- Kyaw Min KhantRichmond$51K
- Jacob BlackwellRichmond$49K
- Pranav MankadRichmond$30K
- Vybhav JettyRichmond$20K
- Harsimran SainiRichmond$17K
- David GilliganRichmond$14K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.